Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
FOCUS DIAGNOSTICS, INC.
RANDOX LABORATORIES

Diagnostic Blood Test Developed for Fibromyalgia

By Labmedica International staff writers
Posted on 17 Apr 2013
Cytokine-producing activity of immune cells of fibromyalgia (FM) patients has led to the development of a commercial blood test.

The very real biological condition of FM takes an average of three to five years for someone with the illness to get an accurate diagnosis as hitherto there was no diagnostic blood test to definitively confirm the disorder.

The blood test was developed in conjunction with a study that identified unique immunologic patterns in fibromyalgia patients. Scientists at the University of Illinois at Chicago (UIC; IL USA) measured plasma cytokine levels in a group of 110 patients with a diagnosis of FM and determined responses to mitogen challenges of their peripheral blood mononuclear cells (PBMC). The cytokine levels of these patients were then compared with those in a group of 91 matched healthy controls.

A custom panel of antibody-conjugated beads for measuring eight human cytokines (BioRad Laboratories; Hercules, CA, USA) was used in the assay. The investigators that cytokine levels of stimulated PBMC cultures of healthy control subjects were significantly increased as compared to matched nonstimulated PBMC cultures. In contrast, the concentrations of most cytokines were lower in stimulated samples from patients with FM compared to controls.

The FM Test is the first test to objectively diagnose fibromyalgia via a simple blood test, with results usually available in one week or less. The FM Test was developed by EpicGenetics (Santa Monica, CA, USA), and will cost USD 744. The FM test is a multi-biomarker-based assay, which comprises immune system white blood cell chemokine and cytokine patterns. Patients with fibromyalgia have a significantly dysregulated pattern regarding these proteins. Test results are based upon a 1-100 scoring system, with fibromyalgia patients having scores of 50 and above. The FM Test is more than 93% sensitive and by comparison, the rheumatoid arthritis blood test is only 65% sensitive.

Bruce S. Gillis, MD, MPH, the founder of EpicGenetics, said, “The result was the discovery of a major set of differences in cell-mediated immunity in the fibromyalgia group versus the healthy patient, and this discovery was opposite to what was anticipated. Specifically, while fibromyalgia patients are often considered to be ‘hyper/overactive responders,’ we identified that the fibromyalgia patients had a depressed and dysregulated immune system.” The original study the test was based on was published on December 17, 2012, in the journal BMC Clinical Pathology.

Related Links:

University of Illinois at Chicago
BioRad Laboratories
EpicGenetics




DiagCor Bioscience
VIRCELL
Sekisui Diagnostics
comments powered by Disqus
Life Technologies

Channels

Clinical Chemistry

view channel
Image: The URiSCAN Super Plus reflectance meter (Photo courtesy of YD Diagnostics).

Semiquantitative Urine Dipstick Evaluated for Microalbuminuria Screening

The urine microalbumin test is used as a screening test for the diagnosis of renal complications in diseases, such as diabetic nephropathy, cardiovascular disease, and hypertension. A urine dipstick... Read more

Microbiology

view channel
Image: The adult free-living female Strongyloides stercoralis with a row of eggs within the body of the nematode (Photo courtesy of the CDC - Centers for Disease Control and Prevention).

Rapid Serological Assay Developed for Strongyloidiasis

Several imperfect methods exist for diagnosing strongyloidiasis and stool examination with microscopic identification of larvae considered the gold standard diagnostic procedure, showing good specificity... Read more

Pathology

view channel
Image: The BD Viper LT System for fully automated, integrated molecular testing on a table top analyzer (Photo courtesy of BD Diagnostics).

Modern Methods Accurately Detects Cervical Cancer

The newer Papanicolaou test (Pap tests) and human papilloma virus (HPV) screening more accurately identify precancerous cellular changes that potentially develop into cervical cancer. Compared to a... Read more

Lab Tech.

view channel
Image: RNAscope detects TP63 mRNA expression in human prostate tissue (Photo courtesy of Advanced Cell Diagnostics).

RNA Biomarker Assay Now Manufactured According to Strict ISO Regulatory Criteria

A line of diagnostic kits that measures RNA biomarkers with single-molecule sensitivity is now being manufactured under the stringent requirements of ISO 13485:2003 certification. Advanced Cell Diagnostics, Inc.... Read more

Industry News

view channel

Social Diagnostics Start-Up to Provide Simple, Affordable Tests Worldwide

The Royal Tropical Institute (KIT; Amsterdam, Netherlands) is establishing a nonprofit, social diagnostics company that develops and markets tests for the diagnosis of poverty-related diseases. Infectious diseases have a global impact; they take no account of national borders and influence the stability of societies... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.